Metcela Inc.
PrivateLast Round
Series C
Jun 28, 2022
Total Funding Raised
$34.02M
Company Overview
Metcela Inc. operates in Healthcare & Life Sciences and is based in Kawasaki. Its latest recorded funding round was a Series C round in June 2022.
Metcela Inc. is a biotechnology company that researches and develops fibroblast and stem cell-based therapies for cardiac diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metcela Inc. Comparables
Compare Metcela Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iHeart Japan Corporation | 84% | |
| Heartseed | 84% | |
| Help Therapeutics | 84% |
For institutional investors. Book with your work email.
Metcela Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 28, 2022 | ||||
| Early Funding | Apr 4, 2022 | ||||
| Series B | Jan 4, 2021 | ||||
| Series A | Aug 30, 2018 | ||||
| Seed | Sep 19, 2017 | ||||
Grant | Mar 1, 2017 |
For institutional investors. Book with your work email.
Metcela Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sony Ventures Corporation | Series A, Series C, Series B |
| Shinsei Capital Partners | Series C |
| Tohoku University Venture Partners | Early Funding |
| F-Prime Capital | Series A, Series B |
| UTEC (The University of Tokyo Edge Capital Partners) | Series B |
| New Energy and Industrial Technology Development Organization | Grant |
| Eight Roads Ventures Japan | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2022
$14M round led by Cyberdyne and Cybernics Excellence Japan Fund.
- Apr 4, 2022
Osaka University Venture Capital and Tohoku University Venture Partners participated.
For institutional investors. Book with your work email.
Metcela Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Metcela Inc.'s valuation, stock price, and market status.
Is Metcela Inc. a public or private company?
Metcela Inc. is a private company.
What is the current stock price of Metcela Inc.?
Metcela Inc. is a private company, so its shares have no public market price. Caplight tracks Metcela Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Metcela Inc. worth (valuation)?
Valuation information for Metcela Inc. is not publicly available.
Can I buy Metcela Inc. stock?
Metcela Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Metcela Inc.'s last funding round?
Metcela Inc.'s most recent funding round was Series C on June 28, 2022.
Who are the main investors in Metcela Inc.?
Key investors in Metcela Inc. include UTEC (The University of Tokyo Edge Capital Partners), Beyond Next Ventures.
Will Metcela Inc. IPO soon?
No public IPO plans have been announced for Metcela Inc..
How can I track Metcela Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Metcela Inc.'s shares on secondary markets.